XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Meeting's Over ! Now play your CARDS

<< Previous

Bullboard Posts

Next >>

Comment by Richmondon Sep 07, 2021 3:12pm

113 Views

Post# 33819859

RE:RE:RE:RE:RE:Meeting's Over ! Now play your CARDS

Congrats !!!XORTEX SHAREHOLDERS!!!! $1++++ by the end of thus week!!!! $2++++ by the end of the month.... News Releases to begin!!! TIGHTEN YOUR SEATBELTS!!!!...Xortex-----GOOOOOOoooooooooo!!!!!

SpaceLabs wrote: About time XRX gets RECOGNIZED for what is is in the PIPELINE for the World who suffer from life threatening DISEASES.

Moonrunner wrote: Wait till news starts dropping next week. This is going to be over $1 by the end of the month.